X. Cui, H. Gooch, A. Petty, J. J. Mcgrath, and D. Eyles, Vitamin D and the brain: Genomic and nongenomic actions, Mol Cell Endocrinol, vol.453, pp.131-143, 2017.

V. Landel, D. Stephan, X. Cui, D. Eyles, and F. Feron, Differential expression of vitamin D-associated enzymes and receptors in brain cell subtypes, J Steroid Biochem Mol Biol, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01735376

V. Landel, C. Annweiler, P. Millet, M. Morello, and F. Feron, Vitamin D, Cognition and Alzheimer's Disease: The Therapeutic Benefit is in the D-Tails, J Alzheimers Dis, vol.53, issue.2, pp.419-444, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02282135

G. A. Plotnikoff and J. M. Quigley, Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain, Mayo Clin Proc, vol.78, issue.12, pp.1463-1470, 2003.

A. Lotfi, A. M. Abdel-nasser, A. Hamdy, A. A. Omran, and M. A. El-rehany, Hypovitaminosis D in female patients with chronic low back pain, Clin Rheumatol, vol.26, issue.11, pp.1895-1901, 2007.

M. Mouyis, A. J. Ostor, A. J. Crisp, A. Ginawi, D. J. Halsall et al., Hypovitaminosis D among rheumatology outpatients in clinical practice, Rheumatology (Oxford), vol.47, issue.9, pp.1348-1351, 2008.

K. Atherton, D. J. Berry, T. Parsons, G. J. Macfarlane, C. Power et al., Vitamin D and chronic widespread pain in a white middle-aged British population: evidence from a cross-sectional population survey, Ann Rheum Dis, vol.68, issue.6, pp.817-822, 2009.

S. E. Tague, G. L. Clarke, M. K. Winter, K. E. Mccarson, D. E. Wright et al., Vitamin D deficiency promotes skeletal muscle hypersensitivity and sensory hyperinnervation, J Neurosci, vol.31, issue.39, pp.13728-13738, 2011.

F. Wepner, R. Scheuer, B. Schuetz-wieser, P. Machacek, E. Pieler-bruha et al., Effects of vitamin D on patients with fibromyalgia syndrome: a randomized placebo-controlled trial, Pain, vol.155, issue.2, pp.261-268, 2014.

F. Schreuder, R. M. Bernsen, and J. C. Van-der-wouden, Vitamin D supplementation for nonspecific musculoskeletal pain in non-Western immigrants: a randomized controlled trial, Ann Fam Med, vol.10, issue.6, pp.547-555, 2012.

S. Straube, A. Moore, R. Derry, S. Mcquay, and H. J. , Vitamin D and chronic pain, Pain, vol.141, issue.1-2, pp.10-13, 2009.

E. E. Shipton and E. A. Shipton, Vitamin D Deficiency and Pain: Clinical Evidence of Low Levels of Vitamin D and Supplementation in Chronic Pain States, Pain Ther, vol.4, issue.1, pp.67-87, 2015.

S. Straube, S. Derry, C. Straube, and R. A. Moore, Vitamin D for the treatment of chronic painful conditions in adults, Cochrane Database Syst Rev, vol.2015, issue.5, p.7771

Z. Wu, Z. Malihi, A. W. Stewart, C. M. Lawes, and R. Scragg, Effect of Vitamin D Supplementation on Pain: A Systematic Review and Meta-analysis, Pain Physician, vol.19, issue.7, pp.415-427, 2016.

D. L. De-oliveira, C. Hirotsu, S. Tufik, and M. L. Andersen, The interfaces between vitamin D, sleep and pain, J Endocrinol, vol.234, issue.1, pp.23-36, 2017.

W. C. Yong, A. Sanguankeo, and S. Upala, Effect of vitamin D supplementation in chronic widespread pain: a systematic review and meta-analysis, Clin Rheumatol, vol.36, issue.12, pp.2825-2833, 2017.

M. Helde-frankling and L. Bjorkhem-bergman, Vitamin D in Pain Management, Int J Mol Sci, vol.18, issue.10, 2017.

F. Colotta, B. Jansson, and F. Bonelli, Modulation of inflammatory and immune responses by vitamin D, J Autoimmun, vol.85, pp.78-97, 2017.

F. Sassi, C. Tamone, D. 'amelio, and P. , Vitamin D: Nutrient, Hormone, and Immunomodulator, Nutrients, vol.10, issue.11, 2018.

X. Liu, A. Nelson, X. Wang, M. Farid, Y. Gunji et al., Vitamin D modulates prostaglandin E2 synthesis and degradation in human lung fibroblasts, Am J Respir Cell Mol Biol, vol.50, issue.1, pp.40-50, 2014.

O. Gendelman, D. Itzhaki, S. Makarov, M. Bennun, and H. Amital, A randomized double-blind placebocontrolled study adding high dose vitamin D to analgesic regimens in patients with musculoskeletal pain, Lupus, vol.24, issue.4-5, pp.483-489, 2015.

W. Huang, S. Shah, Q. Long, A. K. Crankshaw, and V. Tangpricha, Improvement of pain, sleep, and quality of life in chronic pain patients with vitamin D supplementation, Clin J Pain, vol.29, issue.4, pp.341-347, 2013.

H. R. Banafshe, M. J. Khoshnoud, A. Abed, M. Saghazadeh, and A. Mesdaghinia, Vitamin D supplementation attenuates the behavioral scores of neuropathic pain in rats, Nutr Neurosci, vol.2018, pp.1-6

J. F. Chabas, D. Stephan, T. Marqueste, S. Garcia, M. N. Lavaut et al., Cholecalciferol (vitamin D(3)) improves myelination and recovery after nerve injury, PLoS One, vol.8, issue.5, p.65034, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01718197

M. Montava, S. Garcia, J. Mancini, Y. Jammes, J. Courageot et al., Vitamin D3 potentiates myelination and recovery after facial nerve injury, Eur Arch Otorhinolaryngol, vol.272, issue.10, pp.2815-2823, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02283027

M. Aouad, V. Zell, P. E. Juif, A. Lacaud, Y. Goumon et al., Etifoxine analgesia in experimental monoarthritis: a combined action that protects spinal inhibition and limits central inflammatory processes, Pain, vol.155, issue.2, pp.403-412, 2014.

M. Aouad, N. Petit-demouliere, Y. Goumon, and P. Poisbeau, Etifoxine stimulates allopregnanolone synthesis in the spinal cord to produce analgesia in experimental mononeuropathy, Eur J Pain, vol.18, issue.2, pp.258-268, 2014.

O. E. Luis-delgado, M. Barrot, J. L. Rodeau, G. Schott, M. Benbouzid et al., Calibrated forceps: a sensitive and reliable tool for pain and analgesia studies, J Pain, vol.7, issue.1, pp.32-39, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00092802

M. Aouad, A. Charlet, J. L. Rodeau, and P. Poisbeau, Reduction and prevention of vincristine-induced neuropathic pain symptoms by the non-benzodiazepine anxiolytic etifoxine are mediated by 3alpha-reduced neurosteroids, Pain, vol.147, issue.1-3, pp.54-59, 2009.

P. Chomczynski and N. Sacchi, Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction, Anal Biochem, vol.162, issue.1, pp.156-159, 1987.

V. Lelievre, Z. Hu, J. Y. Byun, Y. Ioffe, and J. A. Waschek, Fibroblast growth factor-2 converts PACAP growth action on embryonic hindbrain precursors from stimulation to inhibition, J Neurosci Res, vol.67, issue.5, pp.566-573, 2002.

D. A. Fernandes-de-abreu, D. Eyles, and F. Feron, Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases, Psychoneuroendocrinology, vol.34, issue.1, pp.265-277, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00417412

J. M. Lemire, D. C. Archer, L. Beck, and H. L. Spiegelberg, Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions, J Nutr, vol.125, issue.6, pp.1704-1708, 1995.

A. Boonstra, F. J. Barrat, C. Crain, V. L. Heath, H. F. Savelkoul et al., 25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells, J Immunol, vol.167, issue.9, pp.4974-4980, 2001.

L. E. Jeffery, F. Burke, M. Mura, Y. Zheng, O. S. Qureshi et al., 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3, J Immunol, vol.183, issue.9, pp.5458-5467, 2009.

M. T. Cantorna and A. Waddell, The vitamin D receptor turns off chronically activated T cells, Ann N Y Acad Sci, vol.1317, pp.70-75, 2014.

G. Bivona, L. Agnello, and M. Ciaccio, The immunological implication of the new vitamin D metabolism, Cent Eur J Immunol, vol.43, issue.3, pp.331-334, 2018.

S. Navarro, L. Soletto, S. Puchol, J. Rotllant, J. L. Soengas et al., 60 YEARS OF POMC: POMC: an evolutionary perspective, J Mol Endocrinol, vol.56, issue.4, pp.113-118, 2016.

J. Staszkiewicz, M. T. Skowronski, G. Siawrys, T. Kaminski, B. E. Krazinski et al., Expression of proopiomelanocortin, proenkephalin and prodynorphin genes in porcine luteal cells, Acta Vet Hung, vol.55, issue.4, pp.435-449, 2007.

B. Wylot, J. Staszkiewicz, and S. Okrasa, The expression of genes coding for opioid precursors, opioid receptors, beta-LH subunit and GnRH receptor in the anterior pituitary of cyclic gilts, J Physiol Pharmacol, vol.59, issue.4, pp.745-758, 2008.

K. Xu, E. Bastia, and M. Schwarzschild, Therapeutic potential of adenosine A(2A) receptor antagonists in Parkinson's disease, Pharmacol Ther, vol.105, issue.3, pp.267-310, 2005.

S. A. Van-de-pavert, I. J. Clarke, A. Rao, K. E. Vrana, and J. Schwartz, Effects of vasopressin and elimination of corticotropin-releasing hormone-target cells on pro-opiomelanocortin mRNA levels and adrenocorticotropin secretion in ovine anterior pituitary cells, J Endocrinol, vol.154, issue.1, pp.139-147, 1997.

C. Bousquet, M. C. Zatelli, and S. Melmed, Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing, J Clin Invest, vol.106, issue.11, pp.1417-1425, 2000.

J. M. Bian, N. Wu, R. B. Su, and J. Li, Opioid receptor trafficking and signaling: what happens after opioid receptor activation?, Cell Mol Neurobiol, vol.32, issue.2, pp.167-184, 2012.

T. Koch and V. Hollt, Role of receptor internalization in opioid tolerance and dependence, Pharmacol Ther, vol.117, issue.2, pp.199-206, 2008.

H. M. El-shewy, A. Sa, A. Qalam, A. M. Lee, M. H. Kitatani et al., Phospholipase C and protein kinase C-beta 2 mediate insulin-like growth factor II-dependent sphingosine kinase 1 activation, Mol Endocrinol, vol.25, issue.12, pp.2144-2156, 2011.

N. L. Farnsworth, R. L. Walter, A. Hemmati, M. J. Westacott, and R. K. Benninger, Low Level Proinflammatory Cytokines Decrease Connexin36 Gap Junction Coupling in Mouse and Human Islets through Nitric Oxide-mediated Protein Kinase Cdelta, J Biol Chem, vol.291, issue.7, pp.3184-3196, 2016.

G. L. Fell, K. C. Robinson, J. Mao, C. J. Woolf, and D. E. Fisher, Skin beta-endorphin mediates addiction to UV light, Cell, vol.157, issue.7, pp.1527-1534, 2014.

G. R. Souza, J. Talbot, C. M. Lotufo, F. Q. Cunha, T. M. Cunha et al., Fractalkine mediates inflammatory pain through activation of satellite glial cells, Proc Natl Acad Sci U S A, vol.110, issue.27, pp.11193-11198, 2013.

C. Ledent, J. M. Vaugeois, S. N. Schiffmann, T. Pedrazzini, M. El-yacoubi et al., Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor, Nature, vol.388, issue.6643, pp.674-678, 1997.
URL : https://hal.archives-ouvertes.fr/hal-02186991

M. Inoue, I. Shimohira, A. Yoshida, A. Zimmer, H. Takeshima et al., Dose-related opposite modulation by nociceptin/orphanin FQ of substance P nociception in the nociceptors and spinal cord, J Pharmacol Exp Ther, vol.291, issue.1, pp.308-313, 1999.

J. Yang, Y. Yang, J. M. Chen, W. Y. Liu, C. H. Wang et al., Effect of oxytocin on acupuncture analgesia in the rat, Neuropeptides, vol.41, issue.5, pp.285-292, 2007.

Y. C. Ho, H. J. Lee, L. W. Tung, Y. Y. Liao, S. Y. Fu et al., Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition, J Neurosci, vol.31, issue.41, pp.14600-14610, 2011.

K. V. Savelieva, S. Zhao, V. M. Pogorelov, I. Rajan, Q. Yang et al., Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants, PLoS One, vol.3, issue.10, p.3301, 2008.

A. M. Gregus, D. S. Dumlao, S. C. Wei, P. C. Norris, L. C. Catella et al., Systematic analysis of rat 12/15-lipoxygenase enzymes reveals critical role for spinal eLOX3 hepoxilin synthase activity in inflammatory hyperalgesia, FASEB J, vol.27, issue.5, pp.1939-1949, 2013.

A. Yoshida, J. I. Mobarakeh, E. Sakurai, S. Sakurada, T. Orito et al., Intrathecally-administered histamine facilitates nociception through tachykinin NK1 and histamine H1 receptors: a study in histidine decarboxylase gene knockout mice, Eur J Pharmacol, vol.522, issue.1-3, pp.55-62, 2005.

K. Oshio, H. Watanabe, D. Yan, A. S. Verkman, and G. T. Manley, Impaired pain sensation in mice lacking Aquaporin-1 water channels, Biochem Biophys Res Commun, vol.341, issue.4, pp.1022-1028, 2006.

D. H. Roh, H. S. Seo, S. Y. Yoon, S. Song, H. J. Han et al., Activation of spinal alpha-2 adrenoceptors, but not mu-opioid receptors, reduces the intrathecal N-methyl-D-aspartateinduced increase in spinal NR1 subunit phosphorylation and nociceptive behaviors in the rat, Anesth Analg, vol.110, issue.2, pp.622-629, 2010.

H. X. Liu, P. Brumovsky, R. Schmidt, W. Brown, K. Payza et al., Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: selective actions via GalR1 and GalR2 receptors, Proc Natl Acad Sci U S A, vol.98, issue.17, pp.9960-9964, 2001.

A. Lantero, M. Tramullas, F. Pilar-cuellar, E. Valdizan, R. Santillan et al., TGFbeta and opioid receptor signaling crosstalk results in improvement of endogenous and exogenous opioid analgesia under pathological pain conditions, J Neurosci, vol.34, issue.15, pp.5385-5395, 2014.

C. S. Gillespie, D. L. Sherman, S. M. Fleetwood-walker, D. F. Cottrell, S. Tait et al., Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice, Neuron, vol.26, issue.2, pp.523-531, 2000.

N. L. Chillingworth, S. G. Morham, and L. F. Donaldson, Sex differences in inflammation and inflammatory pain in cyclooxygenase-deficient mice, Am J Physiol Regul Integr Comp Physiol, vol.291, issue.2, pp.327-334, 2006.

E. D. Milligan, C. Twining, M. Chacur, J. Biedenkapp, K. O'connor et al., Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats, J Neurosci, vol.23, issue.3, pp.1026-1040, 2003.

D. S. Kim, K. W. Li, A. Boroujerdi, P. Yu, Y. Zhou et al., Thrombospondin-4 contributes to spinal sensitization and neuropathic pain states, J Neurosci, vol.32, issue.26, pp.8977-8987, 2012.

T. J. Shi, M. D. Zhang, H. Zeberg, J. Nilsson, J. Grunler et al., Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db-/db-mouse, a type 2 diabetes model, Proc Natl Acad Sci U S A, vol.110, issue.2, pp.690-695, 2013.

T. K. Pareek, J. Keller, S. Kesavapany, H. C. Pant, M. J. Iadarola et al., Cyclindependent kinase 5 activity regulates pain signaling, Proc Natl Acad Sci, vol.103, issue.3, pp.791-796, 2006.

D. M. Bautista, J. Siemens, J. M. Glazer, P. R. Tsuruda, A. I. Basbaum et al., The menthol receptor TRPM8 is the principal detector of environmental cold, Nature, vol.448, issue.7150, pp.204-208, 2007.

M. Jiang, M. S. Gold, G. Boulay, K. Spicher, M. Peyton et al., Multiple neurological abnormalities in mice deficient in the G protein Go, Proc Natl Acad Sci, vol.95, issue.6, pp.3269-3274, 1998.

A. Sakai, M. Asada, N. Seno, and H. Suzuki, Involvement of neural cell adhesion molecule signaling in glial cell line-derived neurotrophic factor-induced analgesia in a rat model of neuropathic pain, Pain, vol.137, issue.2, pp.378-388, 2008.

L. Li, H. Qin, W. Shi, and G. Gao, Local Nogo-66 administration reduces neuropathic pain after sciatic nerve transection in rat, Neurosci Lett, vol.424, issue.3, pp.145-148, 2007.

M. V. Chao, The p75 neurotrophin receptor, J Neurobiol, vol.25, issue.11, pp.1373-1385, 1994.

Y. Wang, J. Zhu, and H. F. Deluca, Where is the vitamin D receptor?, Arch Biochem Biophys, vol.523, issue.1, pp.123-133, 2012.

D. W. Eyles, P. Y. Liu, J. P. Cui, and X. , Intracellular distribution of the vitamin D receptor in the brain: comparison with classic target tissues and redistribution with development, Neuroscience, vol.268, pp.1-9, 2014.

T. T. Wang, L. E. Tavera-mendoza, D. Laperriere, E. Libby, N. B. Macleod et al., Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes, Mol Endocrinol, vol.19, issue.11, pp.2685-2695, 2005.

S. Han, T. Li, E. Ellis, S. Strom, and J. Y. Chiang, A novel bile acid-activated vitamin D receptor signaling in human hepatocytes, Mol Endocrinol, vol.24, issue.6, pp.1151-1164, 2010.

Z. Schwartz, H. Ehland, V. L. Sylvia, D. Larsson, R. R. Hardin et al., 25-dihydroxyvitamin D(3) and 24R,25-dihydroxyvitamin D(3) modulate growth plate chondrocyte physiology via protein kinase C-dependent phosphorylation of extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase, Endocrinology, vol.1, issue.7, pp.2775-2786, 2002.

M. Peric, S. Koglin, S. M. Kim, S. Morizane, R. Besch et al., IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes, J Immunol, vol.181, issue.12, pp.8504-8512, 2008.

M. Shen and Y. A. , Nicotinamide cooperates with retinoic acid and 1,25-dihydroxyvitamin D(3) to regulate cell differentiation and cell cycle arrest of human myeloblastic leukemia cells, Oncology, vol.76, issue.2, pp.91-100, 2009.

R. Gniadecki, Nongenomic signaling by vitamin D: a new face of Src, Biochem Pharmacol, vol.56, issue.10, pp.1273-1277, 1998.

E. S. Gold, A. H. Diercks, I. Podolsky, R. L. Podyminogin, P. S. Askovich et al., 25-Hydroxycholesterol acts as an amplifier of inflammatory signaling, Proc Natl Acad Sci, vol.111, issue.29, pp.10666-10671, 2014.